Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.

CompletedOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

January 31, 2009

Conditions
HIV Infections
Interventions
DRUG

Tipranavir

DRUG

Ritonavir

low dose

Trial Locations (27)

Unknown

Boehringer Ingelheim Investigational Site, Aachen

Boehringer Ingelheim Investigational Site, Berlin

Boehringer Ingelheim Investigational Site, Bremen

Boehringer Ingelheim Investigational Site, Cologne

Boehringer Ingelheim Investigational Site, Dortmund

Boehringer Ingelheim Investigational Site, Düsseldorf

Boehringer Ingelheim Investigational Site, Erlangen

Boehringer Ingelheim Investigational Site, Frankfurt am Main

Boehringer Ingelheim Investigational Site, Freiburg im Breisgau

Boehringer Ingelheim Investigational Site, Giessen

Boehringer Ingelheim Investigational Site, Halle

Boehringer Ingelheim Investigational Site, Hamburg

Boehringer Ingelheim Investigational Site, Hanover

Boehringer Ingelheim Investigational Site, Homburg/Saar

Boehringer Ingelheim Investigational Site, Karlsruhe

Boehringer Ingelheim Investigational Site, Krefeld

Boehringer Ingelheim Investigational Site, Leipzig

Boehringer Ingelheim Investigational Site, Magdeburg

Boehringer Ingelheim Investigational Site, Mainz

Boehringer Ingelheim Investigational Site, München

Boehringer Ingelheim Investigational Site, Münster

Boehringer Ingelheim Investigational Site, Nuremberg

Boehringer Ingelheim Investigational Site, Oldenburg

Boehringer Ingelheim Investigational Site, Osnabrück

Boehringer Ingelheim Investigational Site, Saarbrücken

Boehringer Ingelheim Investigational Site, Stuttgart

Boehringer Ingelheim Investigational Site, Wuppertal

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY